Given that APP/PS1 mice exhibit detectable Aβ plaques at the age of 6 months (Liu et al., 2020), 10-month-old AD and KOAD mice were examined to determine whether NP65 deficiency would affect Aβ levels and Aβ plaques in AD mice. Here, APP is linked to Alzheimer disease.